Cory Hafer
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 10
- Clostridium difficile and Clostridium perfringens research 2
-
- Bacterial Identification and Susceptibility Testing 6
- Co-authors
- Franklin D. Lowy (6 shared papers)Anne‐Catrin Uhlemann (7 shared papers)John Kornblum (1 shared paper)Maureen Miller (4 shared papers)Qiuhu Shi (4 shared papers)Justin Knox (3 shared papers)Peter Vavagiakis (3 shared papers)F D Lowy (4 shared papers)
- Journals
- Clinical Infectious Diseases (2 papers)PLoS ONE (2 papers)Epidemiology and Infection (1 paper)mBio (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Cory Hafer
10 papers receiving 552 citations
Peers
Comparison fields: 5 of 57
- Clinical Biochemistry 245
- Infectious Diseases 509
- Molecular Medicine 34
- Microbiology 36
- Biotechnology 43
Countries citing papers authored by Cory Hafer
This map shows the geographic impact of Cory Hafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory Hafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory Hafer more than expected).
Fields of papers citing papers by Cory Hafer
This network shows the impact of papers produced by Cory Hafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory Hafer. The network helps show where Cory Hafer may publish in the future.
Co-authors
The 25 scholars most cited alongside Cory Hafer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 161 | |
| 2 | 2012 | 92 | |
| 3 | 2011 | 77 | |
| 4 | 2012 | 46 | |
| 5 | 2011 | 45 | |
| 6 | 2013 | 43 | |
| 7 | 2011 | 41 | |
| 8 | 2013 | 29 | |
| 9 | 2012 | 26 | |
| 10 | 2014 | 10 |
About Cory Hafer
Cory Hafer is a scholar working on Infectious Diseases, Clinical Biochemistry, Molecular Biology, Public Health, Environmental and Occupational Health and Epidemiology, having authored 10 papers that have together received 570 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (10 papers), Bacterial Identification and Susceptibility Testing (6 papers), Bacterial biofilms and quorum sensing (5 papers), Streptococcal Infections and Treatments (3 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Biochemical and Structural Characterization (1 paper), Infective Endocarditis Diagnosis and Management (1 paper) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Clinical Biochemistry (245 citations), Infectious Diseases (509 citations), Molecular Medicine (34 citations), Microbiology (36 citations) and Biotechnology (43 citations). Cory Hafer has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Franklin D. Lowy, Anne‐Catrin Uhlemann, John Kornblum, Maureen Miller, Qiuhu Shi, Justin Knox, Peter Vavagiakis, F D Lowy, Glenny Vasquez and Kent Barbian. Their work appears in journals such as Clinical Infectious Diseases, PLoS ONE, Epidemiology and Infection, mBio and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.